Shingrix Tied to Higher Risk of Ophthalmic Shingles Recurrence
(MedPage Today) -- The recombinant zoster vaccine (RZV; Shingrix) was associated with a significantly increased risk of recurrence of herpes zoster ophthalmicus (HZO), according to a retrospective cohort study. Within 56 days after the start of... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 15, 2024 Category: Infectious Diseases Source Type: news

Shingles Vaccine Offers 4 Years of Protection Shingles Vaccine Offers 4 Years of Protection
Two doses of the recombinant zoster vaccine protect patients for longer than previously known.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 11, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Source Type: news

Two Doses of Recombinant Zoster Vaccine Highly Effective
TUESDAY, Jan. 9, 2024 -- Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning little over four years of follow-up, according to a study published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 9, 2024 Category: Pharmaceuticals Source Type: news

Shingles Vaccine Highly Effective Over 4 Years
(MedPage Today) -- The two-dose recombinant zoster vaccine (RZV; Shingrix) remained highly effective at preventing shingles over a 4-year period in real-world settings, according to a prospective cohort study. Over 4 years, the two-dose regimen... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 9, 2024 Category: American Health Source Type: news

Shingles Vaccine Reduced Zoster Attacks in Patients With IBD
(MedPage Today) -- ORLANDO -- While patients with inflammatory bowel disease (IBD) are historically more prone to herpes zoster attacks, those who received recombinant zoster vaccines had a far lower risk of the painful rash emerging, researchers... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 18, 2023 Category: Gastroenterology Source Type: news

Effectiveness of Live Zoster Vaccine Wanes Over Time
MONDAY, Dec. 11, 2023 -- Live zoster vaccination is initially effective against outcomes, including herpes zoster and admission for herpes zoster, but the effectiveness wanes over time, according to a study published online Nov. 8 in The BMJ.Nicola... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news

Chickenpox vaccine should be given to children on NHS, experts say
Including jab as part of routine immunisations would have ‘really positive impact on health of young children’, says JCVIExplainer: Why is the UK proposing chickenpox vaccines and do we really need them?A vaccine to protect against chickenpox should become a routine childhood jab in the UK, government advisers have said, adding that the move would not only reduce the number of children who become sick from the virus, but also cut the number of serious cases that can become fatal.At present, the jab, known as the varicella vaccination after the varicella zoster virus that causes the disease, is only available on the NHS...
Source: Guardian Unlimited Science - November 14, 2023 Category: Science Authors: Nicola Davis Science corespondent Tags: Chickenpox Society NHS UK news Health Source Type: news

Understanding shingles and the extended vaccination campaign
Autumn saw the start of an NHS vaccination campaign targeting almost a million people with the Shingrix vaccine. Here, nurse consultant Linda Nazarko explains the background to the programme, and advises on diagnosing and treating shingles and its associated complications What is shingles? Shingles is a painful blistering rash caused by reactivation of varicella zoster virus,... Read moreThe post Understanding shingles and the extended vaccination campaign appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - November 14, 2023 Category: Nursing Authors: Jon Lalljee Tags: Clinical Dermatology Older people care Vaccinations and infections shingles varicella zoster virus Source Type: news

Shingles Prevention in Immunocompromised Dermatology Patients Shingles Prevention in Immunocompromised Dermatology Patients
Many immunomodulatory medications used in dermatology can increase the risk of herpes zoster. Review the use of the recombinant zoster vaccine in patients receiving these drugs.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 3, 2023 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

S2 Episode 5: HIV, Primary Care Treatment, and Vaccines S2 Episode 5: HIV, Primary Care Treatment, and Vaccines
Drs Michael S. Saag and David H. Spach discuss HIV and the nuances of primary care treatment, with a special focus on vaccines, including COVID, hepatitis, varicella zoster virus, and mpox.Medscape (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 13, 2023 Category: Infectious Diseases Tags: HIV/AIDS InDiscussion Source Type: news

Eligibility extended for shingles vaccination in England
The shingles vaccination programme in England is changing from September, both on type of vaccine and who is eligible, with priority for over-50s who are immunocompromised. A letter to GPs, local medical committees and NHS leaders said the programme will be moving to two doses of non-live shingles vaccine Shingrix instead of the one-dose Zostavax... Read moreThe post Eligibility extended for shingles vaccination in England appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - July 6, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Latest news Vaccinations and infections Source Type: news

Lower Dementia Risk May Be Linked With Shingles Vaccine
(MedPage Today) -- The shingles vaccine may be linked with a 20% lower dementia risk, an analysis of 300,000 health records suggested. Receiving the herpes zoster vaccine (Zostavax) reduced the probability of a new dementia diagnosis over 7 years... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 12, 2023 Category: Psychiatry Source Type: news

GSK rolls out its Shingles vaccine in India
The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilitating pain and rashes caused by the reactivation of the varicella zoster virus (VZV). VZV is the same virus that causes chickenpox. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 24, 2023 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q and A: Shingles -- not just a band of blisters
DEAR MAYO CLINIC: A friend recently went through a bout of shingles. I really don't know much about this condition, but I know it was painful. How do you get it? Is there a treatment or vaccine for it? ANSWER: Shingles, also known as herpes zoster, is a common condition caused by the varicella-zoster virus, which also causes chickenpox. Not everyone who has had chickenpox will develop shingles. However, after years of lying dormant in nerve tissue… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2022 Category: Databases & Libraries Source Type: news

Large U.S. Study Finds No Link Between COVID Vaccine and Shingles
(MedPage Today) -- No association was detected between COVID-19 vaccination and herpes zoster infection in a database study involving more than 2 million individuals in the U.S. Using a self-controlled risk interval (SCRI) analysis, the risk of... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 16, 2022 Category: Dermatology Source Type: news